Government affairs. FDA Arthritis Advisory Committee Meeting.
D000707:Anaphylaxis / Q000139:chemically induced; D004341:Drug Evaluation; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use*; D010166:Palliative Care; D011758:Pyrroles / Q000009:adverse effects*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014046:Tolmetin / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use
D011758:Pyrroles; C020549:zomepirac; D014046:Tolmetin; D007052:Ibuprofen